Single- and Multiple-Dose Pharmacokinetics and Tolerability of Gepirone Extended-Release

By Timmer C.J.  

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 819-826

Adis International

Access to resources Recommend Favorite

Effect of Age on the Pharmacokinetics and Pharmacodynamics of Prasugrel during Multiple Dosing: An Open-Label, Single-Sequence, Clinical Trial

By Small David S.  

Drugs & Aging, Vol. 26, Iss. 9, 2009-09 ,pp. : 781-790

Adis International

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exenatide Extended-Release: A Review of Its Use in Type 2 Diabetes Mellitus

By Scott Lesley J.  

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1679-1707

Adis International

Access to resources Recommend Favorite